Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|---|---|
SK-BR-3 | Neratinib | 0.031623 | EGFR/HER2 | RTK | 0.0194 | 0.21796 |
PDXHCI002 | Tivantinib | 1.0 | MET | RTK | -0.3731 | 0.60360 |
SK-BR-3 | Neratinib | 0.1 | EGFR/HER2 | RTK | -0.0389 | 0.24447 |
SK-BR-3 | Neratinib | 0.31623 | EGFR/HER2 | RTK | -0.1447 | 0.30230 |
PDXHCI002 | Tivantinib | 0.01 | MET | RTK | 1.0723 | 0.00111 |
SK-BR-3 | Neratinib | 1.0 | EGFR/HER2 | RTK | -0.2514 | 0.36911 |
MCF 10A | Cediranib | 0.031623 | VEGFR/cKIT | RTK | 1.0136 | 0.00006 |
SK-BR-3 | Neratinib | 3.1623 | EGFR/HER2 | RTK | -0.2530 | 0.36589 |
PDXHCI002 | Tivantinib | 0.031623 | MET | RTK | 1.0374 | 0.01073 |
PDXHCI002 | Neratinib | 0.31623 | EGFR/HER2 | RTK | 0.3928 | 0.01351 |
PDXHCI002 | Neratinib | 1.0 | EGFR/HER2 | RTK | 0.1846 | 0.05265 |
SK-BR-3 | Tivantinib | 0.0031623 | MET | RTK | 1.0607 | 0.00171 |
PDXHCI002 | Ceritinib | 10.0 | ALK | RTK | -0.6341 | 0.73056 |
PDXHCI002 | Neratinib | 0.031623 | EGFR/HER2 | RTK | 0.6460 | -0.00351 |
SK-BR-3 | Tivantinib | 0.01 | MET | RTK | 1.0436 | 0.00173 |
SK-BR-3 | Tivantinib | 0.031623 | MET | RTK | 1.0714 | 0.00950 |
MCF 10A | Cediranib | 1.0 | VEGFR/cKIT | RTK | 1.0068 | 0.00027 |
SK-BR-3 | Tivantinib | 0.1 | MET | RTK | 0.8779 | 0.04583 |
SK-BR-3 | Tivantinib | 0.31623 | MET | RTK | 0.4015 | 0.18097 |
PDXHCI002 | Ceritinib | 0.31623 | ALK | RTK | 0.5616 | 0.00577 |
PDXHCI002 | Ceritinib | 3.1623 | ALK | RTK | -0.6054 | 0.72078 |
MCF 10A | Cediranib | 3.1623 | VEGFR/cKIT | RTK | 0.9680 | -0.00217 |
SK-BR-3 | Tivantinib | 1.0 | MET | RTK | -0.3029 | 0.52635 |
SK-BR-3 | Tivantinib | 3.1623 | MET | RTK | -0.3294 | 0.54882 |
MCF 10A | Cediranib | 10.0 | VEGFR/cKIT | RTK | 0.4781 | 0.01325 |